HAART impact on prevalence of chronic otitis media in Brazilian HIV-infected children
- PMID: 17143430
- PMCID: PMC9445638
- DOI: 10.1016/s1808-8694(15)30997-6
HAART impact on prevalence of chronic otitis media in Brazilian HIV-infected children
Abstract
The advent of new antiretroviral drugs such as protease inhibitors has generated sensible changes in morbity and mortality in HIV-infected patients.
Objectives: To evaluate the impact of Highly Active Antiretroviral Therapy (HAART) on the prevalence of chronic otitis media in HIV-infected pediatric population.
Methods: We analyzed medical charts of 471 children aged zero to 12 years and 11 months with HIV infection from an Ambulatory of ENT and AIDS. Children were divided according to the age: 0 to 5 years and 11 months and 6 to 12 years and 11 months and classified as having chronic otitis media based on history, physical examination, audiologic and tympanometric data. Prevalence of chronic otitis media, as well as CD4+ lymphocyte count were compared between groups in use of HAART and the group without HAART.
Results: Out of 459 children, 65 (14.2%) had chronic otitis media. We observed that in children aged 0 to 5 years and 11 months who were taking HAART there was significant lower prevalence of chronic otitis media (p=0.02). The use of HAART was associated to higher mean CD4+ lymphocyte count (p<0.001).
Conclusion: The use of HAART was associated to reduction in prevalence of chronic otitis media in HIV infected children, probably due to increase in mean CD4+ lymphocyte count.
Similar articles
-
Oral lesions in Brazilian HIV-infected children undergoing HAART.Int J Pediatr Otorhinolaryngol. 2006 Jun;70(6):1089-96. doi: 10.1016/j.ijporl.2005.11.010. Epub 2006 Jan 6. Int J Pediatr Otorhinolaryngol. 2006. PMID: 16406081
-
Otitis media in Brazilian human immunodeficiency virus infected children undergoing antiretroviral therapy.J Laryngol Otol. 2007 Nov;121(11):1048-54. doi: 10.1017/S0022215107006093. Epub 2007 Feb 26. J Laryngol Otol. 2007. PMID: 17319998
-
Rhinosinusitis in HIV-infected children undergoing antiretroviral therapy.Braz J Otorhinolaryngol. 2009 Jan-Feb;75(1):70-5. doi: 10.1016/s1808-8694(15)30834-x. Braz J Otorhinolaryngol. 2009. PMID: 19488563 Free PMC article.
-
Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Verh K Acad Geneeskd Belg. 2001. PMID: 11813503 Review.
-
[Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].Parassitologia. 2004 Jun;46(1-2):89-93. Parassitologia. 2004. PMID: 15305694 Review. Italian.
Cited by
-
Pathophysiology and mechanisms of hearing impairment related to neonatal infection diseases.Front Microbiol. 2023 Apr 14;14:1162554. doi: 10.3389/fmicb.2023.1162554. eCollection 2023. Front Microbiol. 2023. PMID: 37125179 Free PMC article. Review.
-
Hearing loss in perinatally HIV-infected and HIV-exposed but uninfected children and adolescents.Pediatr Infect Dis J. 2012 Aug;31(8):835-41. doi: 10.1097/INF.0b013e31825b9524. Pediatr Infect Dis J. 2012. PMID: 22549437 Free PMC article.
-
Words-in-Noise Test Performance in Young Adults Perinatally HIV Infected and Exposed, Uninfected.Am J Audiol. 2020 Mar 5;29(1):68-78. doi: 10.1044/2019_AJA-19-00042. Epub 2020 Jan 31. Am J Audiol. 2020. PMID: 32004075 Free PMC article.
-
High Prevalence of Antibiotic-Resistant Otitis Media-Associated Bacterial Flora of Asymptomatic People Living with HIV at Morogoro Hospital, Tanzania.J Int Assoc Provid AIDS Care. 2018 Jan-Dec;17:2325958218759761. doi: 10.1177/2325958218759761. J Int Assoc Provid AIDS Care. 2018. PMID: 29534655 Free PMC article.
-
HEARING LOSS AMONG ADOLESCENTS ON ANTIRETROVIRAL THERAPY: A NEED FOR PERIODIC HEARING ASSESSMENT.Ann Ib Postgrad Med. 2019 Jun;17(1):14-18. Ann Ib Postgrad Med. 2019. PMID: 31768151 Free PMC article.
References
-
- UNAIDS – Global HIV/AIDS 2004 report. Available at: http://www.unaids.org/EN/other/functionalities/search.asp. Accessed May 9, 2005
-
- Secretaria de Vigilância em saúde, Ministério da Saúde – Brasil Programa nacional de DST e AIDS (Brasil) Casos de AIDS (números e percentual) em indivíduos com 13 anos de idade ou menos, segundo categoria de exposição hierarquizada por sexo e ano de diagnóstico, 1980-2004. Boletim Epidemiológico AIDS e DST. 2004;1(1):32. Available at: http://www.aids.gov.br/final/dados/BOLETIM2.pdf. Accessed March 3, 2005.
-
- Hoare S. HIV infection in children – impact upon ENT doctors. Int J Pediatr Otorhinolaryngol. 2003;67(S1):S85–S90. - PubMed
-
- Gortmaker SL, Hughes M, Cervia J, et al. Effects of Combination Therapy Including Protease Inhibitors on Mortality Among Children and Adolescents Infected with HIV-1. N Eng J Med. 2001;345(21):1522–1528. - PubMed
-
- Miziara ID, Valentini M, Romano FR, Miniti A. Changing patterns of buccal manifestations in AIDS. Rev Laryngol Otol Rhinol. 2002;123(4):231–234. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous